The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pneumonitis (interstitial lung disease/ILD)
Causality assessment wide ranging
Publications
Sansoninto-induced Lung Injury.
Internal medicine (Tokyo, Japan). 2022;61(24):3709-3712
Tahara M, Yamasaki K, Ikegami H, Fukuda Y, Uchimura K, Tachiwada T, Noguchi S, Kawanami T, Kido T, Mukae H, Yatera K
[A Case of Drug-Induced Lung Injury Caused by Kamikihito].
Journal of UOEH. 2019;41(1):51-56
Pneumonitis with Diffuse Alveolar Hemorrhage Induced by Sho-seiryu-to.
Internal medicine (Tokyo, Japan). 2017;56(19):2623-2626
Japanese herbal medicine-induced pneumonitis: A review of 73 patients.
Respiratory investigation. 2017;55(2):138-144
Ayurvedic medicine and the lung.
Respiration; international review of thoracic diseases. 2014;87(5):428-31
[A case of drug-induced pneumonitis caused by saikokeishikankyoto].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society. 2011;49(9):688-91